Europe : A Geographical Survey of the Continent R. E. H. Mellor E. A. Smith

Autor: Lucas, G. R.

Publikováno v: Geography, 1980 Apr 01. 65(2), 157-157.

Externí odkaz: https://www.jstor.org/stable/40569244

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.

Autor: Scott E; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Hodgson K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Calle B; The Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT, London, UK.; Department of Chemistry, Imperial College London, W12 0BZ, London, UK., Turner H; Cellular Pathology, The Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK., Cheung K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Bermudez A; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, 94304, USA., Marques FJG; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, 94304, USA., Pye H; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Yo EC; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Islam K; Department of Life Technologies, Division of Biotechnology, University of Turku, Turku, Finland., Oo HZ; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., McClurg UL; Institute for Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK., Wilson L; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK., Thomas H; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK., Frame FM; Cancer Research Unit, Department of Biology, University of York, Heslington, North Yorkshire, YO10 5DD, UK., Orozco-Moreno M; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Bastian K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Arredondo HM; The Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK., Roustan C; Structural Biology Science Technology Platform, The Francis Crick Institute, NW1 1AT, London, UK., Gray MA; Sarafan Chem-H and Departemnt of Chemistry, Stanford University, 424 Santa Teresa St, Stanford, CA, 94305, USA., Kelly L; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Tolson A; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Mellor E; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Hysenaj G; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Goode EA; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Garnham R; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Duxfield A; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Heavey S; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Stopka-Farooqui U; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Haider A; Department of Pathology, UCLH NHS Foundation Trust, London, UK., Freeman A; Department of Pathology, UCLH NHS Foundation Trust, London, UK., Singh S; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Johnston EW; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Punwani S; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Knight B; NIHR Exeter Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., McCullagh P; Department of Pathology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., McGrath J; Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Crundwell M; Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Harries L; Institute of Biomedical and Clinical Sciences, Medical School, College of Medicine and Health, University of Exeter, Exeter, UK., Bogdan D; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Westaby D; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK.; Prostate Cancer Targeted Therapy Group, The Royal Marsden Hospital, London, SM2 5PT, UK., Fowler G; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Flohr P; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Yuan W; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Sharp A; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK.; Prostate Cancer Targeted Therapy Group, The Royal Marsden Hospital, London, SM2 5PT, UK., de Bono J; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK.; Prostate Cancer Targeted Therapy Group, The Royal Marsden Hospital, London, SM2 5PT, UK., Maitland NJ; Cancer Research Unit, Department of Biology, University of York, Heslington, North Yorkshire, YO10 5DD, UK., Wisnovsky S; University of British Columbia, Faculty of Pharmaceutical Sciences, Vancouver, BC, V6T 1Z3, Canada., Bertozzi CR; Howard Hughes Medical Institute, 424 Santa Teresa St, Stanford, CA, 94305, USA., Heer R; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, UK., Guerrero RH; University of Zaragoza, Mariano Esquillor s/n, Campus Rio Ebro, Edificio I+D, Zaragoza, Spain; Fundación ARAID, 50018, Zaragoza, Spain.; Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark., Daugaard M; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Leivo J; Department of Life Technologies, Division of Biotechnology, University of Turku, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Whitaker H; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Pitteri S; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, 94304, USA., Wang N; The Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK., Elliott DJ; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Schumann B; The Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT, London, UK.; Department of Chemistry, Imperial College London, W12 0BZ, London, UK., Munkley J; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK. Jennifer.munkley@ncl.ac.uk.

Publikováno v: Oncogene [Oncogene] 2023 Mar; Vol. 42 (12), pp. 926-937. Date of Electronic Publication: 2023 Feb 01.

Police response to out-of-hospital cardiac arrest: The importance of confidence.

Autor: Mellor E; Warwick Medical School, University of Warwick, Coventry, UK., Couper K; Warwick Medical School, University of Warwick, Coventry, UK; Critical Care Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Electronic address: k.couper@warwick.ac.uk.

Publikováno v: Resuscitation [Resuscitation] 2022 Jun; Vol. 175, pp. 1-2. Date of Electronic Publication: 2022 Apr 11.